|
| Promalignant properties of STAT3 during chronic inflammation |
|
https://doi.org/10.18632/oncotarget.482
|
| 359-360 |
|
| Attacking tumor cells with a dual ligand for innate immune receptors |
|
https://doi.org/10.18632/oncotarget.484
|
| 361-362 |
|
| Accelerating cancer evolution: a dark side of SIRT1 in genome maintenance |
|
https://doi.org/10.18632/oncotarget.487
|
| 363-364 |
Reviews
|
| Targeting Cancer Gene Therapy with Magnetic Nanoparticles |
|
https://doi.org/10.18632/oncotarget.490
|
| 365-370 |
|
| Two hits are better than one: targeting both phosphatidylinositol 3kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment |
|
https://doi.org/10.18632/oncotarget.477
|
| 371-394 |
Brief Reports
|
| Metformininduced preferential killing of breast cancer initiating CD44+CD24/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
|
https://doi.org/10.18632/oncotarget.488
|
| 395-398 |
Research Papers
|
| Aggressiveness of human melanoma xenograft models is promoted by aneuploidydriven gene expression deregulation |
|
https://doi.org/10.18632/oncotarget.473
|
| 399-413 |
|
| Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance |
|
https://doi.org/10.18632/oncotarget.519
|
| 414-425 |
|
| Properties of MechanoTransduction via Simulated Microgravity and its Effects on Intracellular Trafficking of VEGFR’s |
|
https://doi.org/10.18632/oncotarget.472
|
| 426-434 |
|
| Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling Glucose regulatory protein 78 and AMPK |
|
https://doi.org/10.18632/oncotarget.483
|
| 435-449 |
|
| Methylation profiling of normal individuals reveals mosaic promoter methylation of cancerassociated genes |
|
https://doi.org/10.18632/oncotarget.480
|
| 450-461 |
|
| On the presence and role of human genebody DNA methylation |
|
https://doi.org/10.18632/oncotarget.497
|
| 462-474 |
|
| Singular v Dual Inhibition of SNF2L and Its Isoform SNF2LT Have Similar Effects on DNA Damage but Opposite Effects on the DNA Damage Response Cancer Cell Growth Arrest and Apoptosis |
|
https://doi.org/10.18632/oncotarget.479
|
| 475-489 |
|
| BCL2L10 is a predictive factor for resistance to Azacitidine in MDS and AML patients |
|
https://doi.org/10.18632/oncotarget.481
|
| 490-501 |
Methodological Reports
|
| Comprehensive Assessment of Potential Multiple Myeloma Immunoglobulin Heavy Chain VDJ Intraclonal Variation Using Massively Parallel Pyrosequencing |
|
https://doi.org/10.18632/oncotarget.469
|
| 502-513 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
